Bench-to-Bedside: How Basic and Clinical Scientists can work to improve drug safety and efficacy

Here is your daily, non-COVID, non-US election, non-massive world ending disaster post for the day. It's nice to get something like this these days. If you look at the common pathway of drug development, you will notice something like this: Pre-clinical -> Phase I -> Phase II -> Phase II -> Phase IV. Without going [...]